Use of doxorubicin-eluting bead transarterial chemoembolization for unresectable hepatocellular carcinoma with portal vein invasion: a prospective study.

Published in: Journal of liver cancer (2023)

DEB-TACE may be a therapeutic option for advanced HCC patients with PVI.

Keyphrases